Facebook
Linkedin
Mail
X
Youtube
Home
Latest News
Features
Interventional Oncology
Profiles
Media
Videos
Podcasts
Events
Supplements
Past Issues
Subscribe
Search
Facebook
Linkedin
Mail
X
Youtube
Interventional News
Home
Latest News
Features
Interventional Oncology
Profiles
Media
Videos
Podcasts
Events
Supplements
Past Issues
Subscribe
Tag: gem
Boston Scientific announces acquisition of Obsidio
15th August 2022
Boston Scientific has announced the acquisition of Obsidio, a privately held company that has developed the Gel Embolic Material (GEM) technology used for embolization...